<DOC>
	<DOCNO>NCT01405456</DOCNO>
	<brief_summary>The purpose study test effect drug , eplerenone , along lifestyle modification affect sugar metabolism , body fat distribution , cardiovascular health HIV-infected individual . In non-HIV-infected individual , recent data show aldosterone , hormone regulate salt water balance , increased association increase belly fat decrease insulin sensitivity . In HIV-infected individual , aldosterone appear high individual increase belly fat , increase aldosterone appear strongly associate impaired sugar metabolism . In study , investigator test effect eplerenone , medication block action aldosterone , along lifestyle modification . The investigator hypothesize eplerenone may improve sugar metabolism , improve marker cardiovascular health , reduce fat accumulation liver muscle .</brief_summary>
	<brief_title>Eplerenone HIV Associated Abdominal Fat Accumulation</brief_title>
	<detailed_description>The study 12 month long , two phase . In initial , 6-month phase , volunteer randomly assign receive either eplerenone placebo ( inactive pill ) . In addition , volunteer receive counsel healthy diet lifestyle , ask follow guideline healthy level physical activity . In second 6-months study , volunteer continue receive lifestyle modification receive eplerenone .</detailed_description>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>1 . Increased waist circumference base NCEP guideline ( &gt; 102cm men &gt; 88cm woman ) impair glucose tolerance ( either IFG &gt; 100 mg/dL &lt; 126 mg/dL 2hr glucose &gt; 140 mg/dl &lt; 200 mg/dL , fast insulin &gt; 12 uIU/mL ) 2 . HIV positive 5y stable ART regimen least 12 month 3 . Age ≥ 30 ≤ 65 year age 1 . ACE Inhibitor , ARB , verapamil , spironolactone 2 . Potassium supplementation 3 . Estimated GFR &lt; 60 , creatinine &gt; 1.5 mg/dL 4 . Serum K &gt; 5.5 mEq/L , ALT &gt; 2.5 time upper limit normal , Hgb &lt; 11g/dL 5 . Uncontrolled hypertension ( SBP ≥ 160 DBP ≥ 100 ) 6 . Current prior steroid use within past 6 month 7 . Known history diabetes mellitus current use antidiabetic medication 8 . Concomitant use full dose ritonavir , nelfinavir , clarithromycin strong inhibitor CYP34A 9 . Use St. John 's Wart ( CYP3A4 inducer ) 10 . Pregnant actively seek pregnancy , breastfeed 11 . For woman : Pregnant actively seek pregnancy , breastfeeding , failure use acceptable nonhormonal form birth control , include abstinence , barrier contraceptive , nonhormonal IUD . 12 . Estrogen progestational derivative use within 3 month 13 . Testosterone use nonphysiologic purpose , physiologic testosterone replacement &lt; 3 month . 14 . Current growth hormone growth hormone release hormone use 15 . Current viral , bacterial infection ( exclude HIV ) 16 . Current active substance abuse 17 . Patients significant history cardiovascular disease , include prior MI stroke</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HIV-infection</keyword>
	<keyword>eplerenone</keyword>
	<keyword>aldosterone</keyword>
	<keyword>visceral fat</keyword>
	<keyword>lipodystrophy</keyword>
</DOC>